Immediate and long-term effects of glucomannan on total ghrelin and leptin in type 2 diabetes mellitus

Diabetes Research and Clinical Practice

Volumn 83, Issue 2, 2009, Pages

  Chearskul, S ^a   Kriengsinyos, W ^b   Kooptiwut, S ^a   Sangurai, S ^a   Onreabroi, S ^a   Churintaraphan, M ^a   Semprasert, N ^a   Nitiyanant, W ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Ghrelin; Glucomannan; Leptin; Type 2 diabetes mellitus

Indexed keywords

GHRELIN; INSULIN; LEPTIN; MANNAN; PLACEBO;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; GLUCOSE TOLERANCE TEST; HORMONE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; FASTING; GHRELIN; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; LEPTIN; MANNANS; PLACEBOS; POSTPRANDIAL PERIOD; TIME FACTORS;

EID: 58249115254     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.11.014     Document Type: Article

References (10)

1. Higgins S.C., Gueorguiev M., and Korbonits M. Ghrelin, the peripheral hunger hormone. Ann. Med. 39 (2007) 116-136
2. Meier U., and Gressner A.M. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin. Chem. 50 (2004) 1511-1525
3. Anderwald C., Brabant G., Bernroider E., et al. Insulin-dependent modulation of plasma ghrelin and leptin concentrations is less pronounced in type 2 diabetic patients. Diabetes 52 (2003) 1792-1798
4. Erdmann J., Lippl F., Wagenpfeil S., and Schusdziarra V. Differential association of basal and postprandial plasma ghrelin with leptin, insulin, and type 2 diabetes. Diabetes 54 (2005) 1371-1378
5. Wauters M., Considine R.V., Yudkin J.S., Peiffer F., De Leeuw I., and Van Gaal L.F. Leptin levels in type 2 diabetes: associations with measures of insulin resistance and insulin secretion. Horm. Metab. Res. 35 (2003) 92-96
6. Vuksan V., Jenkins D.J., Spadafora P., et al. Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial. Diabetes Care 22 (1999) 913-919
7. Chearskul S., Sangurai S., Nitiyanant W., Kriengsinyos W., Kooptiwut S., and Harindhanavudhi T. Glycemic and lipid responses to glucomannan in Thais with type 2 diabetes mellitus. J. Med. Assoc. Thai. 90 (2007) 2150-2157
8. Katsuki A., Urakawa H., Gabazza E.C., et al. Circulating levels of active ghrelin is associated with abdominal adiposity, hyperinsulinemia and insulin resistance in patients with type 2 diabetes mellitus. Eur. J. Endocrinol. 151 (2004) 573-577
9. Cummings D.E., Purnell J.Q., Frayo R.S., Schmidova K., Wisse B.E., and Weigle D.S. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50 (2001) 1714-1719
10. Fruehwald-Schultes B., Oltmanns K.M., Kern W., Born J., Fehm H.L., and Peters A. The effect of experimentally induced insulin resistance on the leptin response to hyperinsulinaemia. Int. J. Obes. Relat. Metab. Disord. 26 (2002) 510-516